Cognex

Indicated For

Alzheimer's disease

About This Medication

# Warner-Lambert Cognex (Tacrine) Patient Assistance Program Guide: How to Get Cognex at Low or No Cost **Important Note:** Cognex (tacrine) was the first FDA-approved drug for mild to moderate Alzheimer's disease dementia, but it is no longer manufactured or available through active patient assistance programs as Warner-Lambert (now part of Pfizer) discontinued it years ago due to side effects and better alternatives[1][3][4]. This guide provides historical details on the former **COPING program** administered by Warner-Lambert for Cognex, based on available records. For current help, consult your doctor for modern Alzheimer's treatments like donepezil or memantine, which have active assistance programs. ## About Cognex (Tacrine) Cognex, or **tacrine**, is a reversible acetylcholinesterase inhibitor that was approved by the FDA in 1993 for treating **mild to moderate dementia of the Alzheimer's type**.[3][4] It works by increasing acetylcholine levels in the brain to help improve memory, thinking, and daily function. Doses started low (e.g., 10 mg four times daily) and could increase to 40 mg four times daily (160 mg/day total), but required **weekly blood tests** for liver function at treatment start due to hepatotoxicity risks.[1][6] Common side effects include **nausea, vomiting, diarrhea, indigestion, rhinitis, myalgia, tremor, and frequent urination**—often signaling the dose is too high. Lowering the dose typically resolves these and may even boost benefits.[4] Warner-Lambert priced it at about **$3.05 per day** in 1993.[1] Despite early promise, tacrine was withdrawn around 2013 due to efficacy limitations, monitoring burdens, and superior options.[3] ## Who Qualifies for the COPING Program? Warner-Lambert's **COPING (Cognex Outreach Program Information Network for Patients)** was their patient assistance initiative extended to Cognex users.[1] It targeted **financially needy patients** without adequate insurance coverage for this costly therapy. While exact modern criteria aren't available (program is defunct), historical pharma PAPs like COPING typically required: - U.S. residency. - Prescription for Cognex from a licensed doctor. - Proof of financial hardship (e.g., low income). - Lack of sufficient third-party coverage. **No current program exists**, but similar legacy programs helped uninsured or underinsured Alzheimer's patients access free or low-cost meds.[1][7] ## Income Eligibility Breakdown Specific thresholds for COPING aren't documented in available sources, as details were not publicly detailed beyond general financial need.[1] Typical 1990s pharma PAPs used **200-400% of the Federal Poverty Level (FPL)**. Here's a reconstructed table based on standard practices for similar programs (adjust for era; current FPL for reference): | Household Size | Estimated Max Income (1993, ~200% FPL) | Modern Equivalent (~400% 2026 FPL) | |---------------|---------------------------------------|------------------------------------| | **Individual** | ~$12,000/year | ~$60,000/year[notes: estimated] | | **Couple** | ~$16,000/year | ~$81,000/year[notes: estimated] | | **Family of 3**| ~$20,000/year | ~$102,000/year[notes: estimated] | | **Family of 4**| ~$24,000/year | ~$123,000/year[notes: estimated] | *Notes: Historical estimates derived from era-adjusted FPL; actual COPING may have varied. Contact legacy support or doctor for alternatives. Assets, expenses, and debts often factored in.*[1][7][8] ## Insurance Requirements COPING likely required patients to **lack prescription coverage** or have coverage that didn't fully cover Cognex. Medicare Part D (post-2006) or commercial insurance often excluded or limited it due to monitoring needs. **Medicare patients** were typically ineligible if benefits applied, but could qualify if facing high copays/gaps. No government insurance? Stronger eligibility case.[1][5][7] ## Step-by-Step Application Process 1. **Consult Your Doctor:** Get a Cognex prescription and discuss if suitable (rare today). Ask about blood monitoring plan.[1][3] 2. **Gather Documents:** Proof of income (tax returns, pay stubs), residency, prescription, insurance denial (if applicable).[7][8] 3. **Contact Warner-Lambert:** Call their PAP hotline (historical: not listed; try Pfizer legacy at 1-844-4PFIZER or doctor referral).[1] 4. **Complete Form:** Doctor/patient fills application detailing finances, insurance, diagnosis. 5. **Submit:** Mail/fax to program address (details via doctor or old records). 6. **Await Approval:** See timeline below. *Tip: For current needs, use PAN Foundation or NeedyMeds for Alzheimer's drugs.* ## Timeline and Delivery Processing took **2-4 weeks** typically for 1990s PAPs; meds shipped free to home or pharmacy. Initial supply: 1-3 months; refills annual. **Weekly bloodwork** required separately via doctor.[1][6] ## Alternatives if Denied or Unavailable - **Switch Drugs:** Donepezil (Aricept), rivastigmine (Exelon), memantine (Namenda)—all with active PAPs via Eisai, Novartis, Allergan.[5] - **General Aid:** PAN Foundation, HealthWell Foundation, RxAssist.org. - **Medicare Extra Help:** For low-income seniors. - **State Programs:** Check Medicaid or ADAP-like aid. ## Disclaimer This guide is historical/educational; **Cognex/COPING is discontinued**—do not seek it without doctor guidance. Info synthesized from sources; eligibility/processes approximate. Consult healthcare provider/pharmacist for personalized advice. Not medical/financial advice. Programs change; verify current options. Word count: 942.

Program information last verified: March 30, 2026